CeeNU

Active Ingredient(s): Lomustine, CCNU
FDA Approved: * August 4, 1976
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

Lomustine (INN); abbreviated as CCNU; original brand name CeeNU, now marketed as Gleostine) is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as streptozotocin. It is a highly lipid-soluble drug,[2] thus it crosses the blood-brain barrier. This property makes it ideal for treating brain tumors, which is its primary use, although it is also used to treat Hodgkin lymphoma as a second-line option.[3&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ceenu 10 mg Oral Capsule
NDC: 0015-3030
Labeler:
E.r. Squibb & Sons, L.L.C.
Ceenu 40 mg Oral Capsule
NDC: 0015-3031
Labeler:
E.r. Squibb & Sons, L.L.C.
Ceenu 100 mg Oral Capsule
NDC: 0015-3032
Labeler:
E.r. Squibb & Sons, L.L.C.